Your browser doesn't support javascript.
loading
Role of 68Ga-Prostate-Specific Membrane Antigen PET/CT in Disease Assessment in Glioblastoma Within 48 Hours of Surgery.
Gupta, Manoj; Choudhury, Partha Sarathi; Premsagar, Ishwar Chandra; Gairola, Munish; Ahlawat, Parveen.
Affiliation
  • Gupta M; From the Departments of Nuclear Medicine.
  • Choudhury PS; From the Departments of Nuclear Medicine.
  • Premsagar IC; Neuro & Spine Oncology Services.
  • Gairola M; Radiotherapy, Rajiv Gandhi Cancer Institute and Research Centre, Delhi, India.
  • Ahlawat P; Radiotherapy, Rajiv Gandhi Cancer Institute and Research Centre, Delhi, India.
Clin Nucl Med ; 45(3): 204-205, 2020 Mar.
Article in En | MEDLINE | ID: mdl-31977462
ABSTRACT
Within 48 hours after surgery, disease assessment in glioblastoma is a challenge for both the clinician and the radiologist. Certain technical and logistical issues prevail in this period. Ga-prostate-specific membrane antigen PET/CT is a known molecular imaging marker in prostate cancer. Its role in high-grade gliomas has been recently discussed. We present a case of a 39-year-old man with recurrence glioblastoma of the right frontal lobe and underwent resurgery. After surgery, Ga-prostate-specific membrane antigen PET/CT showed residual disease along the posterior and inferior margin of the postoperative cavity.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Postoperative Complications / Brain Neoplasms / Glioblastoma / Positron Emission Tomography Computed Tomography Limits: Adult / Humans / Male Language: En Journal: Clin Nucl Med Year: 2020 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Postoperative Complications / Brain Neoplasms / Glioblastoma / Positron Emission Tomography Computed Tomography Limits: Adult / Humans / Male Language: En Journal: Clin Nucl Med Year: 2020 Document type: Article